Paper35276232
Metabolic tricks of cancer cells.
Hönigova K and 5 others. Biochim Biophys Acta Rev Cancer, 2022. Cited by 67 papers, by iCite.
Cite this record
ConductScience Library. Metabolic tricks of cancer cells. Papers, record 35276232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35276232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Tumor Microenvironment | Major topic |
| Cell Transformation, Neoplastic | |
| Energy Metabolism | |
| Humans | |
| Metabolic Networks and Pathways |
Source PubMed
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42931978 | SLC25A39: A key regulator of mitochondrial metabolism and a promising therapeutic target in cancer. | Med Oncol | 2026 | https://conductscience.org/library/papers/42931978 | PubMed |
| 42446694 | Direct targeting of GLUT1 in cancer: A decade of inhibitor discovery and medicinal chemistry insights. | Med Chem Res | 2026 | https://conductscience.org/library/papers/42446694 | PubMed |
| 42266688 | Diagnostic value and immune microenvironment regulatory network of metabolic reprogramming in chronic rhinosinusitis with nasal polyps identified by multidimensional transcriptome integration and machine learning. | Front Immunol | 2026 | https://conductscience.org/library/papers/42266688 | PubMed |
| 42243615 | TPC2 regulates proteomic remodeling, bioenergetic phenotypes, and mitochondrial stress adaptation in melanoma. | Saudi Pharm J | 2026 | https://conductscience.org/library/papers/42243615 | PubMed |
| 42183218 | Decoding the spatiotemporal dynamics of tumor immune niche remodeling in cancer immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42183218 | PubMed |
| 41913584 | Stromal NNMT overexpression as an independent prognostic biomarker in lung adenocarcinoma and breast carcinoma. | Carcinogenesis | 2026 | https://conductscience.org/library/papers/41913584 | PubMed |
| 41711904 | Thrombosis-related gene signature predicts prostate cancer recurrence and immune therapy: insights from retrospective cohorts, bioinformatics, and experimental validation. | Inflamm Res | 2026 | https://conductscience.org/library/papers/41711904 | PubMed |
| 41477177 | SGLT2 Inhibitors in Combination Therapies for Tumors: A Novel Approach to Synergistic Treatment Strategies. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/41477177 | PubMed |
| 41248423 | Mitochondrial Transfer Rescues Respiration to Support De Novo Pyrimidine Biosynthesis and Tumor Progression. | Cancer Res | 2026 | https://conductscience.org/library/papers/41248423 | PubMed |
| 40940894 | The Targeted Inhibition of Histone Lysine Demethylases as a Novel Promising Anti-Cancer Therapeutic Strategy-An Update on Recent Evidence. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40940894 | PubMed |
| 40860196 | METTL16 Promotes Lipid Metabolic Reprogramming and Colorectal Cancer Progression. | Int J Biol Sci | 2025 | https://conductscience.org/library/papers/40860196 | PubMed |
| 40693878 | Hypoxia-Induced Suppression of FAM99A and FAM99B Contributes to the Development and Glucose Metabolic Reprogramming of Hepatocellular Carcinoma. | FASEB J | 2025 | https://conductscience.org/library/papers/40693878 | PubMed |
| 40574800 | Metabolic reprogramming and prognostic modeling in pancreatic cancer: insights from WGCNA. | Front Genet | 2025 | https://conductscience.org/library/papers/40574800 | PubMed |
| 40330094 | Dietary Fiber and Cancer Management: A Twenty-Five-Year Bibliometric Review of Research Trends and Directions. | Biomed Res Int | 2025 | https://conductscience.org/library/papers/40330094 | PubMed |
| 40270890 | Recent advances in biomimetic nanodelivery systems for cancer Immunotherapy. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40270890 | PubMed |
| 39713255 | Targeting hexokinase 2 to enhance anticancer efficacy of trichosanthin in HeLa and SCC25 cell models. | ADMET DMPK | 2024 | https://conductscience.org/library/papers/39713255 | PubMed |
| 39468126 | Glutamine and serum starvation alters the ATP production, oxidative stress, and abundance of mitochondrial RNAs in extracellular vesicles produced by cancer cells. | Sci Rep | 2024 | https://conductscience.org/library/papers/39468126 | PubMed |
| 39009589 | PRMT1 promotes Warburg effect by regulating the PKM2/PKM1 ratio in non-small cell lung cancer. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/39009589 | PubMed |
| 38972297 | Navigating the redox landscape: reactive oxygen species in regulation of cell cycle. | Redox Rep | 2024 | https://conductscience.org/library/papers/38972297 | PubMed |
| 38841361 | L-arginine combination with 5-fluorouracil inhibit hepatocellular carcinoma cells through suppressing iNOS/NO/AKT-mediated glycolysis. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38841361 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35276232
GET https://conductscience.org/api/papers/v1/35276232/cited_by?page=2